According to the latest report by IMARC Group, titled “Metagenomics Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2021-2026”, the global metagenomics market reached a value of US$ XX Million in 2020. Looking forward, IMARC Group expects the market to grow at a CAGR of XX% during 2021-2026. Metagenomics refers to the study of microbial genomes in their natural environment. It involves cloning of genome to study evolution, ecology, diversity, etc., thereby bypassing the requirement for isolation and laboratory cultivation of individual species. Metagenomics assists in gaining scientific insights utilizing sequencing and bioinformatics technologies and is used as a molecular tool to analyze the deoxyribonucleic acid (DNA) acquired from the environmental samples through soil, water, and human waste. These samples are further processed by sequence reading, gene prediction, binning, functional annotation, etc. The insights are useful for diagnosing infectious diseases, gut microbe characterization, environmental remediation, developing biofuels, etc.
We are regularly tracking the direct effect of COVID-19 on the market, along with the indirect influence of associated industries. These observations will be integrated into the report.
Request Free Sample Report: https://www.imarcgroup.com/metagenomics-market/requestsample
Metagenomics Market Trends:
The rising prevalence of numerous infectious diseases, including diarrhea, hepatitis B, HIV/AIDS, etc., is one of the primary factors driving the metagenomics market. Moreover, the escalating demand for effective solutions for the timely diagnosis of neuroinfectious ailments, such as encephalitis and meningitis, is further bolstering the market growth. Additionally, metagenomics is also gaining traction for identifying bacterial pathogens causing foodborne disease outbreaks. Compared to conventionally used technologies, metagenomics needs fewer pre-sequencing steps, offers greater authenticity of long readings, provides high read accuracy, etc. Furthermore, various technological developments, including the integration of next-generation sequencing services with data analysis software for faster analysis and sample processing, will continue to catalyze the global metagenomics market growth over the forecasted period.
Key Market Segmentation:
The competitive landscape of the market has been studied in the report with the detailed profiles of the key players operating in the market.
Some of these key players include:
- Agilent Technologies Inc
- Eurofins Scientific
- Hoffmann-La Roche AG (Roche Holding AG)
- Illumina Inc, Novogene Co. Ltd.
- Oxford Nanopore Technologies Limited
- Pacific Biosciences of California Inc.
- PerkinElmer Inc.
- QIAGEN N.V.
- Swift Biosciences Inc. (Danaher Corporation)
- Thermo Fisher Scientific Inc.
Breakup by Product:
- Instruments and Software
Breakup by Technology:
Breakup by Application:
- Infectious Disease Diagnosis
- Environmental Remediation
- Gut Microbe Characterization
Breakup by Region:
- Middle East and Africa
- North America
- Latin America
Key highlights of the Report:
- Market Performance (2015-2020)
- Market Outlook (2021-2026)
- Porter’s Five Forces Analysis
- Market Drivers and Success Factors
- SWOT Analysis
- Value Chain
- Comprehensive Mapping of the Competitive Landscape
Note: If you need specific information that is not currently within the scope of the report, we can provide it to you as a part of the customization.
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.
30 N Gould St, Ste R
Sheridan, WY (Wyoming) 82801 USA
Tel No:(D) +91 120 433 0800
Americas:- +1 631 791 1145 | Africa and Europe :- +44-702-409-7331 | Asia: +91-120-433-0800, +91-120-433-0800